About
Kenneth Jiao is currently an analyst at Suvretta Capital Management, LLC, based in New York, NY. In this capacity, he leverages his analytical expertise to support the firm's investment decision-making process, focusing on developing financial models and conducting deep sector research.
Mr. Jiao has nearly a decade of professional experience in the investment industry, with a career that has encompassed roles at other prominent financial institutions. While specifics regarding his sector or asset class focus at Suvretta Capital Management are not publicly available, Suvretta is known for its engagement in long/short equity strategies, suggesting Kenneth may have exposure to public equities across various sectors.
Kenneth Jiao's contributions reflect strong quantitative skills and a commitment to rigorous analysis, supported by his educational background and industry credentials. His expertise is sought after in New York’s competitive investment landscape, as evidenced by his long tenure and consistent advancement within the sector.
Career History
| Organization | Role | Date Range | Details |
|---|---|---|---|
| Suvretta Capital Management, LLC | Analyst | Sep 2023 to Present | — |
| JPMorgan Chase & Co. | Investment Banking Analyst | Jun 2022 to Aug 2023 | Healthcare Group |
| Adage Capital Management | Summer Analyst | Oct 2020 to Jun 2022 | — |
| Locust Bioventures | Co-Founder and Co Director | Jun 2020 to Jun 2022 | — |
| University of Pennsylvania | Undergraduate Research Assistant | Feb 2020 to Jun 2022 | Dr. Jon Yoon's Laboratory |
| The National Institutes of Health | Research Intern | Jun 2020 to Aug 2020 | Worked in the All of Us research program, CMSO team. Used SQL with Python to performed population analysis on Severe Maternal Morbidity and Mortality. |
| Oncoceutics, Inc. | Senior Intern | Nov 2018 to Jul 2020 | Developing novel therapies for gliomas and other difficult to treat cancers |
| University of Alabama at Birmingham | Research Assistant Intern | May 2016 to Dec 2019 | Project Title: Retain CHD7, an Epigenetic Regulator, in the Nucleus to Combat Breast Cancer Metastasis |
Education
University of Pennsylvania
Bachelor of Arts - BA, Computational Biology
2018 — 2022
The Wharton School
Bachelor of Science - BS, Finance, General
2018 — 2022
Indian Springs School
2013 — 2018
Others at Suvretta Capital Management, LLC (8)
| Name | Role | Location |
|---|---|---|
A Aleksandr Rabodzey | Managing Director | Menlo Park, CA , United States |
 | Analyst | United States |
 | Managing Director | New York, NY , United States |
 | Analyst | New York, NY , United States |
 | Managing Director and Consumer Sector Head | New York, NY , United States |
D David F. | Analyst | — |
 | Analyst | New York, NY , United States |
 | Capital Markets and Trading and Research Analyst | New Canaan, CT , United States |